Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

Facial sedation scale in horses (FaceSed).

More »

Fig 1 Expand

Table 1.

Content validity of FaceSed developed to evaluate the degree of sedation in horses.

More »

Table 1 Expand

Table 2.

Intra-rater reliability of FaceSed and numerical rating scales between the first and second observations (confidence interval).

More »

Table 2 Expand

Table 3.

Inter-rater matrix comparison of FaceSed and numerical rating scale scores among all evaluators.

More »

Table 3 Expand

Table 4.

Responsiveness of FaceSed, numerical rating scale, and HHAG% over time and between treatments.

More »

Table 4 Expand

Fig 2.

FaceSed (A) and numerical rating scale (B) scores before and after grouped treatments (ACPL, ACPH, DL, DLM, DH, and DHM).

ACPL + ACPH—low and high dose acepromazine, DL + DLM—low dose detomidine and associated with methadone, DH and DHM—high dose detomidine and associated with methadone. Different symbols indicate significant differences between them (p<0.05). † > ‡> § >¶.

More »

Fig 2 Expand

Table 5.

Load values, eigenvalues, and variance of FaceSed items by principal component analysis.

More »

Table 5 Expand

Fig 3.

FaceSed principal component analysis biplot.

Confidence ellipses were built according to the moments before and after sedation. Baseline (green); Peak of sedation (red); Intermediate (purple); End of sedation (blue). The ellipses on the left represent the absence or end of sedation and on the right represent the peak or intermediate sedation. The time-points peak and intermediate sedation influence all items on the scale since their vectors are directed to these ellipses.

More »

Fig 3 Expand

Table 6.

Spearman item-total correlation and internal consistency of each FaceSed item.

More »

Table 6 Expand

Table 7.

FaceSed sensitivity and specificity.

More »

Table 7 Expand

Fig 4.

Area under the curve (AUC) and two-graph ROC curve with the diagnostic uncertainty zone.

Interpretation of AUC: > 0.90 presents high discriminatory capacity. The two-graph ROC curve estimates the diagnostic uncertainty zone of the cut-off point according to the Youden index.

More »

Fig 4 Expand

Fig 5.

Frequency distribution of FaceSed scores before and after sedation/tranquilisation.

ACPL + ACPH—acepromazine in low and high doses, DL + DLM—detomidine in low dose and associated with methadone, DH and DHM—detomidine in high dose and associated with methadone.

More »

Fig 5 Expand